Michela Borghesan Selected Research

macroH2A histone

2/2016	DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
1/2016	Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis.
1/2014	SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michela Borghesan Research Topics

Disease

2	Carcinogenesis 02/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2014 - 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	COVID-19 10/2020
1	Adenocarcinoma 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 02/2016
1	Disease Progression 02/2016
1	Fibrosis (Cirrhosis) 02/2016
1	Thinness 01/2016
1	Liver Diseases (Liver Disease) 01/2013
1	Insulin Resistance 01/2013

Drug/Important Bio-Agent (IBA)

3	macroH2A histoneIBA 02/2016 - 01/2014
3	Histones (Histone)IBA 02/2016 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2020 - 02/2016
2	Protein Isoforms (Isoforms)IBA 02/2016 - 01/2016
1	abemaciclibIBA 01/2022
1	PolymersIBA 01/2018
1	MucinsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 02/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	Sirtuin 1IBA 01/2014
1	ChromatinIBA 01/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 02/2016
1	Therapeutics 10/2020